Regulatory Access Asphalion operates across Europe with offices in Barcelona, Madrid, Munich and London, offering regulatory affairs, safety consulting and lifecycle support for drugs, biologics, biosimilars, ATMPs and medical devices. This positions them as a potential partner for pharma and biotech companies seeking European market access and post-approval compliance.

Global Collaboration They serve hundreds of clients worldwide through partnerships across continents, enabling accelerated worldwide regulatory activities with local expertise. This suggests opportunities for global expansion projects, cross-border registrations, and regional regulatory strategy services.

Sustainability & Compliance Asphalion is a member of Medicines for Europe and has been awarded as a sustainable company by EcoVadis, signaling strong ESG credentials. This can be leveraged when engaging clients prioritizing sustainable practices and regulatory submissions with sustainability considerations.

Growth & Talent With a team of over 100 experts and recent leadership addition as Operations Director, the company demonstrates growth momentum and enhanced operational capacity, indicating readiness for larger or more complex projects, including program management and regulatory program expansion.

Training & Thought Leadership Recent launches of regulatory training initiatives and collaborations, such as the Navarra Health Cluster program and training cycles on regulatory challenges, point to opportunities for upsell into training, capability-building engagements, and advisory services alongside core consulting.